The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESSO 2024 | The unpredictability of cancer outcomes: Dr Mitsuru Sasako on personalized care and offering hope
Mitsuru Sasako, MD, PhD, Yodogawa Christian Hospital, Osaka, Japan, discusses the unpredictability of cancer outcomes, even in early-stage disease, based on his experience as a surgical oncologist. He recalls cases of unexpected recurrences in stage one patients and instances of prolonged survival in those with advanced-stage disease, like liver metastasis. Dr Sasako emphasizes the importance of personalized, shared decision-making with patients and staying open to applying new knowledge, including insights from subgroup analyses. He believes that while a cure cannot always be promised, it’s essential never to give up and to offer patients hope and tailored treatment options. This interview took place at the ESSO 43 Congress in Antwerp, Belgium.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
